Monaco Asset Management SAM Takes $26.86 Million Position in Teladoc Health, Inc. $TDOC

Key Points

• Monaco Asset Management SAM acquired 3.17 million Teladoc shares worth approximately $26.86 million, making TDOC its second-largest holding and representing 2.1% of its portfolio.
• Teladoc reported quarterly EPS of -$0.21, beating estimates, but revenue of $606.93 million missed expectations and declined 4% year over year. The company remains unprofitable and guided to continued losses for fiscal 2026.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and average price target of $7.54; recent target changes ranged from $7.50 to $10.50. Insiders sold shares primarily to cover tax obligations tied to equity awards.

Monaco Asset Management SAM acquired a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,167,979 shares of the health services provider's stock, valued at approximately $26,864,000. Teladoc Health comprises 2.1% of Monaco Asset Management SAM's portfolio, making the stock its 2nd biggest holding. Monaco Asset Management SAM owned 1.74% of Teladoc Health at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the stock. Creative Planning increased its holdings in Teladoc Health by 7.7% in the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider's stock valued at $159,000 after purchasing an additional 1,462 shares during the last quarter. Versant Capital Management Inc lifted its stake in Teladoc Health by 33.3% during the second quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider's stock worth $70,000 after purchasing an additional 2,052 shares in the last quarter. Syon Capital LLC lifted its stake in Teladoc Health by 19.1% during the fourth quarter. Syon Capital LLC now owns 14,140 shares of the health services provider's stock worth $99,000 after purchasing an additional 2,264 shares in the last quarter. ProShare Advisors LLC lifted its stake in Teladoc Health by 8.2% during the fourth quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider's stock worth $228,000 after purchasing an additional 2,457 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in shares of Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider's stock worth $31,000 after buying an additional 2,810 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Stock Up 0.2%

Shares of TDOC stock opened at $6.82 on Monday. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.89. The stock has a market capitalization of $1.24 billion, a PE ratio of -6.89 and a beta of 2.12. The firm has a 50 day moving average of $8.15 and a two-hundred day moving average of $6.57.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.04. The business had revenue of $606.93 million for the quarter, compared to analysts' expectations of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company's revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period last year, the firm earned ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. Analysts expect that Teladoc Health, Inc. will post -0.89 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Adam C. Vandervoort sold 7,906 shares of the business's stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $60,322.78. Following the completion of the transaction, the insider directly owned 110,261 shares of the company's stock, valued at approximately $841,291.43. The trade was a 6.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the sale, the insider directly owned 57,671 shares in the company, valued at approximately $440,029.73. This represents a 9.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 39,195 shares of company stock worth $299,058 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of research reports. Citigroup dropped their price objective on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Weiss Ratings raised Teladoc Health from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, May 22nd. Bank of America raised their target price on Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group dropped their target price on Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Five analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $7.54.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source